2009: 101/3 (Mar) pp. 413-603

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

36 articles
21.
[Add to basket]
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis

Panteleimon Kountourakis1,*; Amanda Psyrri1,*; Andreas Scorilas2; Sonia Markakis3; Diane Kowalski4; Robert L. Camp4; Eleftherios P. Diamandis5; Meletios A. Dimopoulos6

1Department of Medical Oncology, Yale University, School of Medicine, New Haven, Connecticut, USA; 2Department of Biology, University of Athens, School of Medicine, Athens, Greece; 3Department of Pathology; University of Athens, School of Medicine, Athens, Greece; 4Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut, USA; 5Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; 6Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece

Thrombosis and Haemostasis 2009 101 3: 541-546

http://dx.doi.org/10.1160/TH08-01-0052

[Summary] [PDF] [Pay per view]
22.
[Add to basket]
Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation

Soo-Mee Bang1; Jong-Seok Lee1; Jeong Yeal Ahn2; Jae Hoon Lee3; Myung Soo Hyun4; Bong Seog Kim5; Moo Rim Park6; Hyun-Sook Chi7; Ho Young Kim8; Hyo Jung Kim8; Moon Hee Lee9; Hwak Kim10; Jong Ho Won11; Hwi Joong Yoon12; Do-yeun Oh13; Eun-Mi Nam14; Sung Hwa Bae15; Byoung-Kook Kim16; for the Korean MPN Working Party

1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea; Department of 2Laboratory Medicine, and 3Internal Medicine, Gachon University Gil Hospital, Incheon, Korea; 4Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea; 5Department of Internal Medicine, Seoul Veterans Hospital, Seoul, Korea; 6Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea; 7Department of Laboratory Medicine, University of Ulsan College of Medicine, Seoul, Korea; 8Department of Internal Medicine, Hallym University Medical Center, Anyang, Korea; 9Department of Internal Medicine, Inha University Hospital, Incheon, Korea; 10Department of Internal Medicine, Ulsan University Hospital, Ulsan, Korea; 11Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, Korea; 12Department of Internal Medicine, Kyunghee University Hospital, Seoul, Korea; 13Department of Internal Medicine, Pochon CHA University College of Medicine, Seongnam, Korea; 14Department of Internal Medicine, Ewha Women’s University Hospital, Seoul, Korea; 15Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Korea; 16Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

Thrombosis and Haemostasis 2009 101 3: 547-551

http://dx.doi.org/10.1160/TH08-06-0396

[Summary] [PDF] [Pay per view]
23.
[Add to basket]
Subtherapeutic oral anticoagulant therapy: Frequency and risk factors

Eva K. Rombouts1; Frits R. Rosendaal1,2; Felix J. M. van der Meer1

1Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, the Netherlands; 2Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands

Thrombosis and Haemostasis 2009 101 3: 552-556

http://dx.doi.org/10.1160/TH08-09-0626

[Summary] [PDF] [Pay per view]
24.
[Add to basket]
Desmoteplase in acute massive pulmonary thromboembolism

Ulrich Tebbe1; Peter Bramlage2; Andreas Graf3; Peter Lechleitner4; Christoph Bode5; Friedrich-Christian Riess6; Norbert Clemens7,9; Yasir Al-Rawi8,9; Stavros Konstantinides10; Samuel Z. Goldhaber11

1Medical Clinic Lippe-Detmold, Detmold, Germany; 2Institute for Clinical Pharmacology, Medical Faculty Carl Gustav Carus, TU Dresden, Germany; 3Community Hospital Dresden-Friedrichstadt, Dresden, Germany; 4Department of Internal Medicine, General Hospital Lienz, Austria; 5University Clinic Freiburg, Internal Medicine III (Cardiology), Freiburg, Germany; 6Department of Cardiac Surgery, Albertinen Heart Center, Hamburg, Germany; 7CRS Clinical Research Services Mannheim GmbH, Grünstadt, Germany; 8MEGA Pharma Solutions FZE, Ras Al-Khaima, United Arab Emirates; 9Paion AG, Aachen, Germany; 10Department of Cardiology and Pulmonary Medicine, Georg August University of Göttingen, Göttingen, Germany; 11Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2009 101 3: 557-562

http://dx.doi.org/10.1160/TH08-10-0638

[Summary] [PDF] [Pay per view]
25.
[Add to basket]
International normalised ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy

Thomas D. Christensen1; Torben B. Larsen2; Claus Jensen3; Marianne Maegaard1; Benny Sørensen4,5

1Department of Cardiothoracic and Vascular Surgery & Institute of Clinical Medicine, Aarhus University Hospital, Skejby, Aarhus N, Denmark; 2Department of Biochemistry, Pharmacology and Genetics, Section for Thrombosis and Haemostasis, Odense University Hospital, Sdr. Boulevard 29, Odense, Denmark; 3UNI•C, The Danish IT Centre for Education and Research, Aarhus N, Denmark; 4Centre for Hemophilia and Thrombosis, Department of Clinical Biochemistry & Institute of Clinical Medicine, Aarhus University Hospital, Skejby, Aarhus N, Denmark; 5Haemostasis Research Unit, Centre for Haemophilia and Thrombosis, Guy’s and St Thomas NHS Trust Foundation & King’s College London School of Medicine, London, United Kingdom

Thrombosis and Haemostasis 2009 101 3: 563-569

http://dx.doi.org/10.1160/TH08-09-0601

[Summary] [PDF] [Pay per view]
26.
[Add to basket]
Rapid molecular diagnosis of von Willebrand disease by direct sequencing. Detection of 12 novel putative mutations in VWF gene

Online Supplementary Material

Irene Corrales1; Lorena Ramírez1; Carme Altisent2; Rafael Parra1,2; Francisco Vidal1

1Unitat de Diagnòstic i Teràpia Molecular, Banc de Sang i Teixits, Barcelona, Spain; 2Unitat d'Hemofília de l'Hospital General Vall d'Hebron, Barcelona, Spain

Thrombosis and Haemostasis 2009 101 3: 570-576

http://dx.doi.org/10.1160/TH08-08-0500

[Summary] [PDF] [Pay per view]
27.
[Add to basket]
Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population

Marc Lambert1; Gisele Ferrard-Sasson1; Sylvain Dubucquoi2; Eric Hachulla1; Lionel Prin2; Pierre-Yves Hatron1; Jenny Goudemand3; Marie-Claire Boffa4; Claudine Caron3

1Internal Medicine Department, University Hospital, Lille, France; 2 Immunology Laboratory, University Hospital, Lille, France; 3Hemostasis Laboratory, University Hospital, Lille, France; 4Internal Medicine Department, Pitie Salpetriere Hospital, Paris, France

Thrombosis and Haemostasis 2009 101 3: 577-581

http://dx.doi.org/10.1160/TH08-06-0410

[Summary] [PDF] [Pay per view]
28.
[Add to basket]
Acquired haemophilia A associated with transitory and severe factor V deficiency during bullous pemphigoid: First report

Anne Ryman1; Thomas Hubiche2; Jean Amiral3; AlainTaïeb2; Viviane Guerin1

1Haematology Laboratory, University Pellegrin Hospital, Bordeaux, France; 2Department of Dermatology, Saint-Andre Hospital, Bordeaux, France; 3Hyphen Biomed Laboratory, Neuville s/Oise, France

Thrombosis and Haemostasis 2009 101 3: 582-583

http://dx.doi.org/10.1160/TH08-09-0596

[Summary] [PDF] [Pay per view]
29.
[Add to basket]
Myelofibrosis and spinal cord ischaemia

Daniel Periard1; Michael Currat2; Salah Dine Qanadli3; Daniel Hayoz1; Peter Vollenweider2

1Department of Angiology and Medicine, Hôpital Cantonal, Fribourg, Switzerland; 2Department of Internal Medicine, Lausanne University Hospital (CHUV), Switzerland; 3Department of Radiology, Lausanne University Hospital (CHUV), Switzerland

Thrombosis and Haemostasis 2009 101 3: 584-585

http://dx.doi.org/10.1160/TH08-09-0570

[Summary] [PDF] [Pay per view]
30.
[Add to basket]
Induction of tolerance after combined immunosuppression and -adsorption in two patients with acquired haemophilia after severe haemorrhages controlled by sequential administration of rFVIIa and FEIBA

Marcus Stockschläder1; Leilani Ruf2; Anne Linderer3; Thomas Schroeder2; Wolfram T. Knoefel3; Rainer Haas2; Günther Giers1; Andrea Gerhardt1; Christoph Sucker1; Rainer B. Zotz1; Rüdiger E. Scharf1

1Department of Haemostasis and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, Germany; 2Department of Haematology, Oncology, and Clinical Immunology, Heinrich Heine University Medical Center, Düsseldorf, Germany; 3Department of General Surgery, Heinrich Heine University Medical Center, Düsseldorf, Germany

Thrombosis and Haemostasis 2009 101 3: 586-590

http://dx.doi.org/10.1160/TH08-11-0716

[Summary] [PDF] [Pay per view]
31.
[Add to basket]
Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORC1 c.-1639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients

Zoraida Verde1; Catalina Santiago1; Beatriz Valle2; Ana Fernández-Santander1; Fernando Bandrés2; Elpidio Calvo2; Jonatan R. Ruiz3; Alejandro Lucía1; Félix Gómez Gallego1

1Universidad Europea de Madrid, Madrid, Spain; 2Fundación Tejerina, Madrid, Spain; 3Hospital Clínico de San Carlos, Madrid, Spain; 4Department of Biosciences and Nutrition at NOVUM, Unit for Preventive Nutrition, Karolinska Institutet, Huddinge, Sweden

Thrombosis and Haemostasis 2009 101 3: 591-593

http://dx.doi.org/10.1160/TH08-09-0578

[Summary] [PDF] [Pay per view]
32.
[Add to basket]
Thrombin generation test in patients under anticoagulant therapy with vitamin k antagonists

Isabel Brocal; Pascual Marco; Javier Lucas; José Verdú; Fabián Tarín

Thrombosis and Haemostasis Unit, University General Hospital of Alicante, Alicante, Spain

Thrombosis and Haemostasis 2009 101 3: 594-595

http://dx.doi.org/10.1160/TH08-07-0465

[Summary] [PDF] [Pay per view]
33.
[Add to basket]
Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities

Maria Rita Taliani1; Cecilia Becattini1; Giancarlo Agnelli1; Paolo Prandoni2; Marco Moia3; Mario Bazzan4; RosaMaria Salvi5; Walter Ageno6; Giuliana Guazzaloca7; Davide Imberti8; Mauro Silingardi9; Renzo Poggio10; for the Warfarin Optimal Duration Italian Trial (WODIT) Investigators

1Sezione di Medicina Interna e Cardiovascolare, Dipartimento di Medicina Interna, Università di Perugia, Perugia, Italy; 2Dipartimento di Scienze Mediche e Chirurgiche, Università di Padova, Padua, Italy; 3Centro Emofilia e Trombosi, IRCCS Ospedale Maggiore, Milan; 4Unità di Ematologia e Malattie Trombotiche – Cellini Humanitas, Turin, Italy; 5U.O. Medicina d’Urgenza, Ospedale di Cattinara, Trieste, Italy; 6Dipartimento di Medicina Clinica, Università dell’Insubria, Varese, Italy; 7Divisione di Angiologia, Policlinico Sant’ Orsola-Malpighi, Bologna, Italy; 8Thrombosis Center, Emergency Department, Ospedale di Piacenza, Piacenza, Italy; 9Divisione di Medicina Interna I, Arcispedale S. Maria Nuova, Reggio Emilia, Italy; 10II Divisione Medicina Generale – Centro Trombosi, Ospedale Galliera, Genova, Italy

Thrombosis and Haemostasis 2009 101 3: 596-598

http://dx.doi.org/10.1160/TH08-07-0477

[Summary] [PDF] [Pay per view]
34.
[Add to basket]
The significance of ADAMTS13 in a patient with thrombotic thrombocytopenic purpura complicated autoimmune hepatitis

Michiomi Shimizu1; Shosaku Nomura1; Kazuyoshi Ishii1; Youichi Mohri2; Nao Umei3; Satoshi Suzuki3; Yoshio Matsuo3; Ayami Isonishi4; Masanori Matsumoto4; Fumiaki Urase5; Yasuhiro Maeda5; Yoshihiro Fujimura4

1Division of Hematology, Kishiwada City Hospital, Kishiwada, Osaka, Japan; 2Division of Gastroenterology and Hepatology, Kishiwada City Hospital; 3Division of Emergency and Critical Care Medicine, Kishiwada City Hospital; 4Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan; 5Department of Hematology, Kinki University, School of Medicine; Higashi-Osaka City, Japan

Thrombosis and Haemostasis 2009 101 3: 599-600

http://dx.doi.org/10.1160/TH08-09-0606

[Summary] [PDF] [Pay per view]
35.
[Add to basket]
Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation

Arnljot Tveit1; Andreas Bollmann2,3; Ingebjørg Seljeflot4; Daniela Husser2,3; Martin Stridh5; Leif Sörnmo5; Harald Arnesen4; S. Bertil Olsson2; Pål Smith1

1Department of Internal Medicine, Asker and Bærum Hospital, Rud, Norway; 2Department of Cardiology, Lund University, Lund, Sweden; 3Department of Electrophysiology, Heart Center Leipzig, Germany; 4Center for Clinical Heart Research, Ulleval University Hospital, Oslo, Norway; 5Department of Electroscience, Lund University, Lund, Sweden

Thrombosis and Haemostasis 2009 101 3: 601-603

http://dx.doi.org/10.1160/TH08-07-0482

[Summary] [PDF] [Pay per view]
36.
Erratum

Thrombosis and Haemostasis 2009 101 3: 603-603

[Summary] [Free download]
Previous page
1-20 21-36  

Articles

You've 192 Article(s) in your Basket.

Thrombosis News

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...